Nasdaq Cdtx News Today

Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have received an average rating of “Buy” from the four brokerages that are presently covering the company, Marketbeat Ratings reports. Three research analysts have rated the stock with a buy recommendation and one has assigned a strong buy recommendation to the company. The average 1-year […]

Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) gapped up prior to trading on Thursday after Needham & Company LLC raised their price target on the stock from $3.00 to $25.00. The stock had previously closed at $12.29, but opened at $14.50. Needham & Company LLC currently has a buy rating on the […]

Cidara Therapeutics (NASDAQ:CDTX – Get Free Report)‘s stock had its “strong-buy” rating reiterated by stock analysts at WBB Securities in a note issued to investors on Thursday, Benzinga reports. They currently have a $40.00 price target on the biotechnology company’s stock. WBB Securities’ price target would indicate a potential upside of 207.69% from the stock’s […]

Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have received a consensus recommendation of “Buy” from the four analysts that are presently covering the company, MarketBeat reports. Three analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average twelve-month price target […]

Shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) have received an average recommendation of “Buy” from the four brokerages that are presently covering the firm, Marketbeat Ratings reports. Three investment analysts have rated the stock with a buy rating and one has given a strong buy rating to the company. The average 1 […]

Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report)’s stock price was up 7.1% during trading on Wednesday . The stock traded as high as $11.34 and last traded at $10.98. Approximately 23,896 shares traded hands during trading, a decline of 33% from the average daily volume of 35,403 shares. The stock had previously closed at […]

SAN DIEGO, April 22, 2024 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX) (the Company), a biotechnology company using its proprietary...

Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) insider Leslie Tari sold 21,029 shares of Cidara Therapeutics stock in a transaction that occurred on Monday, March 11th. The shares were sold at an average price of $0.67, for a total value of $14,089.43. Following the sale, the insider now directly owns 258,681 shares in the […]

Pale Fire Capital SE purchased a new position in shares of Cidara Therapeutics, Inc. (NASDAQ:CDTX – Free Report) during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 54,356 shares of the biotechnology company’s stock, valued at approximately $51,000. Pale Fire Capital SE […]

Cidara Therapeutics, Inc. (NASDAQ:CDTX – Get Free Report) was the target of a significant decline in short interest in the month of October. As of October 31st, there was short interest totalling 1,240,000 shares, a decline of 6.1% from the October 15th total of 1,320,000 shares. Based on an average trading volume of 466,800 shares, […]